Rituximab in Refractory Primary Membranous Nephropathy

Clinical trial NCT03880643 · COMPLETED

Trial details

NCT number: NCT03880643
Sponsor: Istanbul University
Status: COMPLETED
Study type: OBSERVATIONAL

Glomerulonephritis, Membranous

Start date: 2018-11-01
Primary completion: 2019-05-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.